echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Drugs Articles > Problems related to increasing attention to shortage of drugs in China are expected to be solved

    Problems related to increasing attention to shortage of drugs in China are expected to be solved

    • Last Update: 2018-10-16
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    [market analysis of chinapharma.com] to solve the problem of drug shortage, we should start from the production and supply of raw materials to the use of drugs All links of the whole supply chain are expected to be properly supervised by the government to create a fair and orderly market environment for the drug market But at present, China's drug shortage market is still chaotic What causes this disorder? What causes the frequent shortage of these drugs? It is believed that the price mechanism leads to the weak willingness of pharmaceutical manufacturers to produce and operate; there is a lack of effective monitoring and early warning mechanism and inventory management system for shortage drugs; Some enterprises and upstream and downstream joint monopoly, disrupt the market In terms of price, why can the price of medicine in short time increase dozens of times? Some experts say that is behind the manipulation However, to crack down on these behaviors alone is far from alleviating the shortage and stabilizing the drug price In order to solve the problem of medicine shortage, the relevant departments of the state have issued a series of policies to deal with the disorder and solve the problem In this year's opinions on improving the national basic drug system, 13 references have been made to the shortage of drugs, which shows that the government has paid close attention to the phenomenon of "shortage of drugs" Other data show that, in terms of the time range involved in the shortage of drugs, 218 drugs appear in the shortage monitoring report for five consecutive months; 254 drugs detect the shortage at least four months in five months; there are 304 drugs in three months, and nearly 1200 drugs detect the shortage for another 1-2 months So, how can we solve the problem of drug shortage more effectively? Industry insiders suggest that we need to take multiple measures together and link them On the one hand, strengthen the cooperation of departments and establish the monitoring and early warning mechanism of drug supply; on the other hand, strengthen the supervision of drug supply enterprises in short supply The author has learned that from the data collected in the "short drug monitoring results express and annex" released from January to may, there are nearly 2000 short drugs involved in the national urban public hospitals' short drug monitoring posts, while the number of short drugs involved in the same period of last year is only 860 It can be seen that institutions at all levels pay more attention to the lack of drugs, and the monitoring strength of short drugs is greatly improved High In addition, as early as the end of last year and the beginning of this year, the national development and Reform Commission has issued the guide on price behavior of short drugs and API operators (hereinafter referred to as the "guide"), which defines the monopoly price of short drugs and upstream API, and clearly stipulates eight kinds of "prohibited" price monopoly behaviors On the other hand, how do other countries deal with the shortage of drugs in foreign countries? In the United States, drug price management is hierarchical: for national essential drugs, the federal government pays, purchases, stores and distributes them; For rare diseases and low-cost drugs commonly used in clinic, the government implements direct cash compensation and tax-free subsidies for production enterprises, and major medical insurance companies also have support policies according to laws and regulations Although the overall efficiency is not high, it does fall into practice The health service system in the UK is mainly regulated by the government, and the NHS provides health services for all British citizens based on the national financial and tax support But as a pharmaceutical industry, it is still market-oriented The UK's response to drug shortages is that the NHS closely monitors drug shortages and then resolves them through consultation with pharmaceutical manufacturers In response to the shortage of drugs, all countries have put forward practical measures, and more or less have achieved some results In China, although the shortage of drugs has not been completely solved or effectively controlled, the industry believes that with the continuous national medical reform and the gradual promotion and implementation of various policies to solve the shortage of drugs, the shortage of drugs in China is expected to be gradually solved.
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.